Back to Newsroom
Back to Newsroom

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VRM, KDMN and PTON

Wednesday, 12 May 2021 06:45 PM

The Klein Law Firm

Topic:
Lawsuits
The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-VRM-KDMN-and-PTON 

NEW YORK, NY / ACCESSWIRE / May 12, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Vroom, Inc. (NASDAQ:VRM)
Class Period: June 9, 2020 - March 3, 2021
Lead Plaintiff Deadline: May 21, 2021

During the class period, Vroom, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Vroom had not demonstrated that it was able to control and scale growth in respect to its salesforce to meet the demand for its products; (2) as a result, the Company was forced to discount aged inventory to move through its retail channels or liquidated in its wholesale channels; (3) as a result, the ecommerce gross profit per unit was reasonably likely to decline; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in VRM: http://www.kleinstocklaw.com/pslra-1/vroom-inc-loss-submission-form?id=15787&from=1

Kadmon Holdings, Inc. (NASDAQ:KDMN)
Class Period: October 1, 2020 - March 10, 2021
Lead Plaintiff Deadline: June 2, 2021

The KDMN lawsuit alleges Kadmon Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) the Belumosudil NDA was incomplete and/or deficient; (ii) the additional new data that the Company submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the NDA submission; (iii) accordingly, the initial Belumosudil NDA submission lacked the degree of support that the Company had led investors to believe; (iv) accordingly, the FDA was likely to extend the PDUFA target action date to review the Belumosudil NDA; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in KDMN: http://www.kleinstocklaw.com/pslra-1/kadmon-holdings-inc-loss-submission-form?id=15787&from=1

Peloton Interactive, Inc. (NASDAQ:PTON)
Class Period: September 11, 2020 - April 16, 2021
Lead Plaintiff Deadline: June 28, 2021

The PTON lawsuit alleges that Peloton Interactive, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) in addition to the tragic death of a child, Peloton's Tread+ had caused a serious safety threat to children and pets as there were multiple incidents of injury to both; (2) safety was not a priority to Peloton as defendants were aware of serious injuries and death resulting from the Tread+, yet did not recall or suggest a halt of the use of the Tread+; (3) as a result of the safety concerns, the U.S. Consumer Product Safety Commission ("CPSC") declared that the Tread+ posed a serious risk to public health and safety and urgently recommended that consumers with small children cease using the Tread+; (4) the CPSC also found a safety threat to Tread+ users if they lost their balance; and (5) as a result of the foregoing, defendants' statements about Peloton's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in PTON: http://www.kleinstocklaw.com/pslra-1/peloton-interactive-inc-loss-submission-form?id=15787&from=1

The Klein Law Firm, Wednesday, May 12, 2021, Press release picture

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: